New ICD implanted subcutaneously
Having the benefits of dual-chamber diagnostics without the need for an atrial lead is a true advantage for electrophysiologists," said Dr. Typically, atrial sensing capabilities require the need for an additional lead, creating increased risk of complications. This prospective cohort-controlled trial enrolled patients with a DX system at eight study centers in the U.
Other large studies have reported inappropriate shock rates for single-chamber ICDs as high single chamber icd implant 6 percent at one year. DX also maintained quality atrial sensing amplitudes from implant to month follow up, aiding in the ability to consistently and appropriately detect AHRE.
Further information can be found at clinicaltrials.
References 1Healey JS, et al. Subclinical atrial fibrillation and the risk of stroke.
N Engl J Med. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
J Am Coll Cardiol.
Comparison of a novel, single-lead atrial sensing system with a dual-chamber implantable cardioverter-defibrillator system in patients without antibradycardia pacing indications: results of a randomized study. Circ Arrhythm Electrophysiol.
Lead complications, device infections, and clinical outcomes in the first year after implantation of cardiac resynchronization therapy-defibrillator and cardiac resynchronization therapy-pacemaker. J Cardiovasc Electrophysiol. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year.